Yu Liang-Cai, Zhao Xin, Liu Li-Jun, Li Xiao-Ying, Zhou Jin, Zeng Ping, Zhang Xiao-Qing
Department of Occupational Health, Sleep Medicine Center and ENT, West China School of Public Health and West China Forth Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
Department of Administration, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
Int J Clin Pract. 2022 Jul 14;2022:3622896. doi: 10.1155/2022/3622896. eCollection 2022.
This study aims at exploring the effect of obstructive sleep apnea-hypopnea syndrome (OSAHS) on the liver and kidney function indexes of patients and analyze the changes in these indexes after minimally invasive surgery.
Patients with OSAHS ( = 51) who were diagnosed via polysomnography (PSG) and received minimally invasive surgery in the sleep disorders diagnosis and treatment center of the West China Fourth Hospital of Sichuan University from January 2017 to January 2019 were selected as test subjects and placed in the OSAHS group. At the same time, 79 healthy people with no snoring or breathing difficulties were selected from the medical examination center of the hospital as the control group (tested as normal by PSG). These two groups were used to compare the differences in the related indexes of serum liver and kidney function and evaluate the changes in sleep monitoring and related liver and kidney function indexes in patients with OSAHS after minimally invasive surgery.
The alanine aminotransferase (ALT), aspartate aminotransferase (AST), and uric acid (UA) levels were higher in the OSAHS group (48.98 ± 36.34, 28.88 ± 14.80, and 422.30 ± 98.65, respectively) than in the control group (21.91 ± 11.61, 22.18 ± 6.19, and 330.49 ± 64.45 and = 6.514, 3.549, and 6.373, respectively; < 0.05). Of the patients with OSAHS, 17 were followed up for one year. After minimally invasive surgery, ALT decreased from 44.29 ± 20.61 to 26.47 ± 9.91 ( = 4.395), AST decreased from 27.71 ± 8.32 to 21.82 ± 4.81 ( = 3.673), and UA decreased from 397.35 ± 92.14 umol/L to 362.94 ± 106.76 umol/L ( = 2.580), and these differences were statistically significant ( < 0.05).The changes in ALT ( = -0.635) and AST ( = -0.504) were related to the difference in the lowest blood oxygen saturation ( < 0.05), and the change in UA was related to the difference in the apnea-hypopnea index ( = -0.532, < 0.05).
There are some abnormalities in liver- and kidney-function-related indexes in patients with OSAHS, and minimally invasive surgery can help to improve liver and kidney function in these patients.
本研究旨在探讨阻塞性睡眠呼吸暂停低通气综合征(OSAHS)对患者肝功能和肾功能指标的影响,并分析微创手术后这些指标的变化。
选取2017年1月至2019年1月在四川大学华西第四医院睡眠障碍诊疗中心经多导睡眠图(PSG)诊断并接受微创手术的51例OSAHS患者作为试验对象,纳入OSAHS组。同时,从医院体检中心选取79例无打鼾或呼吸困难的健康人作为对照组(PSG检查正常)。比较两组血清肝功能和肾功能相关指标的差异,评估OSAHS患者微创手术后睡眠监测及相关肝功能和肾功能指标的变化。
OSAHS组丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)和尿酸(UA)水平(分别为48.98±36.34、28.88±14.80和422.30±98.65)高于对照组(分别为21.91±11.61、22.18±6.19和330.49±64.45;P分别为6.514、3.549和6.373;P<0.05)。对51例OSAHS患者中的17例进行了为期1年的随访。微创手术后,ALT从44.29±20.61降至26.47±9.91(P=4.395),AST从27.71±8.32降至21.82±4.81(P=3.673),UA从397.35±92.14 umol/L降至362.94±106.76 umol/L(P=2.580),差异均有统计学意义(P<0.05)。ALT(P=-0.635)和AST(P=-0.504)的变化与最低血氧饱和度差异有关(P<0.05),UA的变化与呼吸暂停低通气指数差异有关(P=-0.532,P<0.05)。
OSAHS患者肝功能和肾功能相关指标存在一定异常,微创手术有助于改善这些患者的肝功能和肾功能。